458
S. Paul, N. Jayaraman / Carbohydrate Research 343 (2008) 453–461
15H, aromatic), 7.07 (d, 2H, J = 8.7 Hz, aromatic), 6.68
(d, 2H, J = 8.7 Hz, aromatic), 5.67 (app. t, 1H,
J = 9.0 Hz, H-3), 5.42 (dd, 1H, J = 7.8, 9.0 Hz, H-2),
5.19 (d, 1H, J = 3.6 Hz, H-10), 4.88–4.53 (m, 7H,
PhCH2, H-1, H-6a, H-6b, H-30, H-40), 4.28–4.13 (m,
3H, H-5, H-60a; H-6b0 ), 4.04 (ddd, 1H, J = 3.5, 4.7,
9.0 Hz, H-50), 3.86–3.75 (band, 4H, H-4, OCH3), 2.13–
1.89 (band, 11H, COCH3, H-20 ; H-20 ); 13C NMR
(CDCl3, 75 MHz): d 170.5, 169.8, 169.7, 166.1, 165.3,
165.1, 159.3, 133.5, 133.4, 133.1, 130.0, 129.8, 129.8,
129.7, 129.6, 129.5, 128.3, 128.2, 113.7, 98.4 (C-1), 98.3
(C-10), 75.5, 75.4, 72.7, 71.7, 70.1, 69.2, 68.9, 68.0,
63.4, 62.0, 55.1 (OCH3), 34.7 (C-20), 20.7, 20.6. HR-
MS m/z: [M+Na]+ calcd for C47H48O17, 907.2789;
found, 907.2783.
(cat.) and MeOH (8 mL), stirred for 6 h at room temper-
ature, quenched with a few drops of AcOH/MeOH
(1:10, v/v) and concentrated. Purification afforded 10
(0.28 g, 66% conversion after 2 steps, a/b = 2:1), as a
1
white foamy solid. Rf = 0.34 (12% MeOH/CHCl3); H
NMR (D2O, 300 MHz): d 7.26–7.23 (band, aromatic),
5.32 (app. d, J = 2.7 Hz, H-10), 5.07 (m, H-3b), 4.93
(br s, H-1a), 4.82–4.64 (band, H-30, H-40, PhCH2,
H-5a, H-4b), 4.52–4.49 (m, H-6aa, H-6ba), 4.35 (app.
d, J = 11.3 Hz, H-1b), 3.85–3.13 (band, H-50,
H-60 ; H-60 , H-3a, H-4a, H-6ab, H-6bb, H-5b), 2.08–
a
e
a
b
1.78 (m, H-2eb, H-20 ; H-20 , H-2aa, H-2ea), 1.64–1.55
a
e
(m, H-2ab); 13C NMR (D2O, 75 MHz): d 137.6, 137.3,
129.5, 129.4, 129.3, 129.1, 99.3 (C-1b), 97.4 (C-1a,
C-10), 77.1, 77.0, 75.5, 74.0, 71.9, 71.8, 71.7, 71.6, 70.2,
69.7, 68.8, 61.9, 61.4, 39.7 (C-2b), 38.0 (C-20), 37.6
(C-2a). HR-MS m/z: [M+Na]+ calcd for C19H28O9,
423.1631; found, 423.1625.
3.5. 4-Methoxybenzyl 4-O-(2-deoxy-3,4,6-tri-O-acetyl-a-
D-lyxo-hexopyranosyl)-2,3,6-tri-O-benzoyl-b-D-gluco-
pyranoside (9)
3.7. Benzyl 4-O-(2-deoxy-a-D-lyxo-hexopyranosyl)-2-
deoxy-D-arabino-hexopyranoside (11)
Compound 9 was prepared according to the method
described for the synthesis of compound 8, using 74
(0.35 g, 1.05 mmol), 3 (0.520 g, 0.95 mmol), 4 A MS
˚
Compound 11 was prepared according to the method
described for the synthesis of compound 10, using 6
(1 g), CH2Cl2 (12 mL), NIS (0.28 g, 1.26 mmol) and
TfOH (11 lL, 0.13 mmol). Purification of the crude
reaction mixture afforded disaccharide 9 (0.39 g, 52%),
as a white foamy solid. Rf = 0.18 (EtOAc/pet ether
˚
(0.28 g, 0.82 mmol), 7 (0.32 g, 0.97 mmol), 4 A MS
(0.8 g), CH2Cl2 (8 mL), NIS (0.26 g, 1.16 mmol) and
TfOH (10 lL, 0.11 mmol). Purification afforded 11
(0.21 g, 64% conversion after 2 steps, a/b = 2:1), as a
24
1:2); ½aꢂD +36.0 (c 1.7, CHCl3); 1H NMR (CDCl3,
1
300 MHz): d 8.14–7.35 (m, 15H, aromatic), 7.06 (d,
2H, J = 8.4 Hz, aromatic), 6.67 (d, 2H, J = 8.4 Hz, aro-
matic), 5.65 (app. t, 1H, J = 9.0 Hz, H-3), 5.42 (dd, 1H,
J = 7.8, 9.0 Hz, H-2), 5.27 (app. s, 1H, H-40), 5.22 (d,
1H, J = 4.5 Hz, H-10), 5.16–5.14 (m, 1H, H-30), 4.80
(app. t, 2H, J = 11.7 Hz, PhCH2), 4.69 (d, 1H,
J = 7.8 Hz, H-1), 4.59–4.53 (m, 2H, H-6a, H-6b). 4.27
(app. t, 1H, J = 6.0 Hz, H-50), 4.13 (app. t, 1H,
J = 9.0 Hz, H-4), 3.98–3.94 (m, 2H, H-60a; H-6b0 ), 3.88–
3.84 (m, 1H, H-5), 3.75 (br s, 3H, OCH3), 2.03–1.77
(band, 11H, H-20 ; COCH3; H-20 ); 13C NMR (CDCl3,
white foamy solid. Rf = 0.23 (12% MeOH/CHCl3); H
NMR (D2O, 300 MHz): d 7.27–7.24 (band, aromatic),
5.33 (br s, H-10), 5.09 (m, H-3b), 4.92 (br s, H-1a),
4.73–4.65 (band, H-30, H-40, PhCH2, H-5a, H-4b),
4.52–4.49 (m, H-6aa, H-6ba), 4.34 (app. d,
J = 10.8 Hz,
H-1b),
3.84–3.18
(band,
H-50,
H-60 ; H-60 , H-3a, H-4a, H-6ab, H-6bb, H-5b), 2.04–
a
b
1.78 (m, H-2eb, H-20 ; H-20 , H-2aa), 1.64–1.55 (m,
a
e
H-2ea), 1.45–1.34 (m, H-2ab); 13C NMR (D2O,
75 MHz): d 137.7, 137.3, 129.5, 129.4, 129.3, 129.2,
129.1, 99.5 (C-1b), 97.4 (C-1a, C-10), 77.2, 75.5, 72.6,
71.9, 70.0, 69.7, 68.3, 65.4, 62.3, 61.8, 61.3, 39.7
(C-2b), 38.0 (C-2a), 32.3 (C-20). HR-MS m/z:
[M+Na]+ calcd for C19H28O9, 423.1631; found, 423.1628.
e
a
75 MHz): d 170.4, 170.0, 169.8, 165.4, 165.2, 159.4,
148.1, 133.5, 133.3, 133.2, 129.8, 129.7, 129.2, 128.8,
128.7, 128.5, 128.3, 128.2, 128.1, 113.7, 99.4 (C-1), 98.4
(C-10), 76.1, 75.4, 72.9, 71.7, 70.0, 69.1, 68.0, 67.9,
66.2, 65.4, 63.6, 62.1, 55.1 (OCH3), 30.1 (C-20), 20.7,
20.6. HR-MS m/z: [M+Na]+ calcd for C47H48O17,
907.2789; found, 907.2762.
3.8. 2-Deoxy-a-D-arabino-hexopyranosyl-(1!4)-D-gluco-
pyranose (12)
To a solution of 8 (0.22 g, 0.25 mmol) in MeCN/H2O
(5:1, v/v, 8 mL), CAN (0.16 g, 0.3 mmol) was added
and stirred at room temperature. After 4 h, the reaction
mixture was diluted with EtOAc (30 mL), washed with
aq NaHSO3, water, dried and concentrated. The residue
was admixed with MeOH (8 mL), NaOMe (cat.) and
stirred for 6 h at room temperature, neutralized with
IR 120 resin (H+) and evaporated. The residue was puri-
fied and freeze-dried to afford 12 (0.07 g, 85%,
a/b = 36:64), as an amorphous solid. Rf = 0.18 (7:2:1
3.6. Benzyl 4-O-(2-deoxy-a-D-arabino-hexopyranosyl)-2-
deoxy-D-arabino-hexopyranoside (10)
Compound 10 was prepared according to the method
described for the synthesis of compound 8, using 4
˚
(0.38 g, 1.13 mmol), 6 (0.36 g, 1.07 mmol), 4 A MS
(0.8 g), CH2Cl2 (8 mL), NIS (0.3 g, 1.35 mmol) and
TfOH (12 lL, 0.13 mmol). After work-up and concen-
tration, the crude product was admixed with NaOMe